The Clorox Company (CLX) M&A Call Transcript
Clorox said the all-cash deal, which is being funded with debt, will help it expand further into the health and hygiene categories.
The Clorox Company is going to report its fiscal Q2 results soon. A shipment headwind and slowing consumption weigh on the quarter's outlook. The focus point is in CLX's outlook past Q2. The company guides growth reacceleration for H2, but growing private label penetration poses a clear threat. Weak growth is already priced in. I estimate CLX stock to have a fair value of $113.
Clorox investors can still clean up on the dividend. Target stock is in the bargain bin, even though the stock has been on the rise recently.
CLX stays a solid hold as brand strength, ERP-driven efficiencies and innovation offset cautious consumers, competition and near-term sales pressure.
After a rough 2025, consumer staples stocks like Clorox are great buys for value investors seeking passive income. Clorox has ripped off the proverbial bandage by guiding for weak results in its current fiscal year.
Clorox ( NYSE:CLX ) operates household brands including Clorox bleach, Glad trash bags, Burt's Bees, Hidden Valley, and Fresh Step cat litter.
Investors need to pay close attention to CLX stock based on the movements in the options market lately.
CLX tests its pricing power as consumers trade down, promotions rise, and margins stay under pressure in a tightening demand environment.
CLX leans on heavier brand investment and new product launches to rebuild momentum as ERP-related disruptions weigh on near-term sales.
Clorox (CLX) faces near-term headwinds, but its 4.6% dividend yield and depressed valuation offer long-term appeal. CLX's FY26 outlook is weak, with sales expected to decline 6–10% and EPS down 21%, but management anticipates improvement in the back half. The digital transformation and product innovation are expected to unlock value, though benefits may take 1–2 years to materialize.
Clorox (CLX) reported earnings 30 days ago. What's next for the stock?